• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alchemia Ltd/Australia

+ Add to Watchlist

AEMAF:US

Price not available for AEMAF:US

Snapshot for Alchemia Ltd/Australia (AEMAF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.0600 52wk Range: 0.0600 - 0.5600 1-Yr Rtn: -

Stock Chart for AEMAF

No chart data available.
  • AEMAF:US 0.0600
  • 1M
  • 1Y
0.0600
Interactive AEMAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEMAF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 7.5681
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) 0.0100
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 324.72
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEMAF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for AEMAF

Alchemia Limited is a biotechnology company that develops carbohydrate based molecules for pharmaceutical applications. The Company's products are used in drug development in the field of antibiotics and anti-cancer drugs.

Tracie RamsdaleExec Dir/Co-FounderJennifer Pilcher "Jenni"Chief Financial Officer
Tracey Jean BrownVP:Oncology/Chief Scientific OfcrStephen Anthony DenaroSecretary
More Company Profile & Key Executives for AEMAF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil